Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer

SOLTI Breast Cancer Research Group · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
breast-cancerpaclitaxelsafety
breast cancer, her2 positive, neoadjuvant, liposomal doxorubicin, paclitaxel, trastuzumab, pertuzumab, safety, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 825865
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.